| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
108,674,000 |
| Market
Cap: |
66.29(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2298 - $2.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 707 |
| Guru Rank Value : 1.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
816,825 |
816,825 |
| Total Buy Value |
$0 |
$0 |
$194,885 |
$194,885 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
4 |
4 |
| Total Shares Sold |
56,192 |
56,192 |
208,638 |
386,254 |
| Total Sell Value |
$40,460 |
$40,460 |
$210,247 |
$883,580 |
| Total People Sold |
5 |
5 |
6 |
9 |
| Total Sell Transactions |
5 |
5 |
18 |
37 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Clark Mitchall G. |
EVP & Chief R & QA Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
188,054 |
|
- |
|
| Haqq Christopher |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$158,451 |
D/D |
(4,426) |
355,604 |
|
- |
|
| Haqq Christopher |
EVP, R&D & Chief Scientific Of |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
360,030 |
|
- |
|
| Newell Joe |
Chief Tech. Operations Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
32,500 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
808,675 |
|
- |
|
| Porter Derrell |
SVP, Head of Global Commercial |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
14,044 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$153,188 |
D/D |
(4,279) |
110,375 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
114,654 |
|
- |
|
| Soffer Gad |
EVP & Chief Strategy Officer |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$142,735 |
D/D |
(3,987) |
269,749 |
|
- |
|
| Soffer Gad |
EVP & Chief Strategy Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
273,736 |
|
- |
|
| Turner Heather D |
EVP, General Counsel & Sec. |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$158,737 |
D/D |
(4,434) |
81,708 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-26 |
4 |
AS |
$35.46 |
$339,558 |
I/I |
(9,300) |
291,678 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-25 |
4 |
AS |
$33.22 |
$340,976 |
I/I |
(10,000) |
300,978 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-24 |
4 |
AS |
$33.20 |
$486,938 |
D/D |
(14,400) |
310,978 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-23 |
4 |
AS |
$34.05 |
$859,606 |
D/D |
(24,100) |
325,378 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-22 |
4 |
AS |
$30.93 |
$330,735 |
I/I |
(10,000) |
349,478 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-16 |
4 |
AS |
$30.38 |
$18,228 |
I/I |
(600) |
359,478 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2018-01-12 |
4 |
AS |
$22.32 |
$828,120 |
D/D |
(33,500) |
89,654 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2018-01-12 |
4 |
OE |
$11.00 |
$330,000 |
D/D |
30,000 |
123,154 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-12 |
4 |
AS |
$30.05 |
$3,005 |
I/I |
(100) |
360,078 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2018-01-11 |
4 |
AS |
$20.77 |
$72,695 |
D/D |
(3,500) |
93,154 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-11 |
4 |
AS |
$21.49 |
$438,900 |
I/I |
(20,000) |
360,178 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2018-01-10 |
4 |
AS |
$19.64 |
$171,938 |
I/I |
(8,600) |
380,178 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2017-12-29 |
4 |
AS |
$18.24 |
$372,628 |
I/I |
(20,000) |
388,778 |
|
- |
|
| Mcgrath John |
EVP & Chief Financial Officer |
• – – |
2017-12-29 |
4 |
AS |
$20.00 |
$640,000 |
D/D |
(32,000) |
96,654 |
|
- |
|
731 Records found
|
|
Page 16 of 30 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (1.06%) 
